HDAC-2 has been found to be up-regulated in HCC, lung, pancreatic, colorectal and breast cancer and it has also been correlated to chemotherapy resistance [34,41,42,43,44,45,46]. This evidence concerns the gene HDAC2 and hepatocellular carcinoma.